Isaac E Hall1, Peter P Reese, Francis L Weng, Bernd Schröppel, Mona D Doshi, Rick D Hasz, William Reitsma, Michael J Goldstein, Kwangik Hong, Chirag R Parikh. 1. Program of Applied Translational Research, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut;, †Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut;, ‡University of Pennsylvania, Philadelphia, Pennsylvania;, §Barnabas Health, Livingston, New Jersey;, ‖University Hospital, Ulm, Germany;, ¶Wayne State University, Detroit, Michigan;, *Gift of Life Institute, Philadelphia, Pennsylvania;, ††New Jersey Sharing Network, New Providence, New Jersey;, ‡‡Mount Sinai School of Medicine and New York Organ Donor Network, New York, New York, §§Section of Nephrology, Veterans Affairs Medical Center, West Haven, Connecticut.
Abstract
BACKGROUND AND OBJECTIVES: The influence of deceased-donor AKI on post-transplant outcomes is poorly understood. The few published studies about deceased-donor preimplant biopsy have reported conflicting results regarding associations between AKI and recipient outcomes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This multicenter study aimed to evaluate associations between deceased-donor biopsy reports of acute tubular necrosis (ATN) and delayed graft function (DGF), and secondarily for death-censored graft failure, first adjusting for the kidney donor risk index and then stratifying by donation after cardiac death (DCD) status. RESULTS: Between March 2010 and April 2012, 651 kidneys (369 donors, 4 organ procurement organizations) were biopsied and subsequently transplanted, with ATN reported in 110 (17%). There were 262 recipients (40%) who experienced DGF and 38 (6%) who experienced graft failure. DGF occurred in 45% of kidneys with reported ATN compared with 39% without ATN (P=0.31) resulting in a relative risk (RR) of 1.13 (95% confidence interval [95% CI], 0.9 to 1.43) and a kidney donor risk index-adjusted RR of 1.11 (95% CI, 0.88 to 1.41). There was no significant difference in graft failure for kidneys with versus without ATN (8% versus 5%). In stratified analyses, the adjusted RR for DGF with ATN was 0.97 (95% CI, 0.7 to 1.34) for non-DCD kidneys and 1.59 (95% CI, 1.23 to 2.06) for DCD kidneys (P=0.02 for the interaction between ATN and DCD on the development of DGF). CONCLUSIONS: Despite a modest association with DGF for DCD kidneys, this study reveals no significant associations overall between preimplant biopsy-reported ATN and the outcomes of DGF or graft failure. The potential benefit of more rigorous ATN reporting is unclear, but these findings provide little evidence to suggest that current ATN reports are useful for predicting graft outcomes or deciding to accept or reject allograft offers.
BACKGROUND AND OBJECTIVES: The influence of deceased-donor AKI on post-transplant outcomes is poorly understood. The few published studies about deceased-donor preimplant biopsy have reported conflicting results regarding associations between AKI and recipient outcomes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This multicenter study aimed to evaluate associations between deceased-donor biopsy reports of acute tubular necrosis (ATN) and delayed graft function (DGF), and secondarily for death-censored graft failure, first adjusting for the kidney donor risk index and then stratifying by donation after cardiac death (DCD) status. RESULTS: Between March 2010 and April 2012, 651 kidneys (369 donors, 4 organ procurement organizations) were biopsied and subsequently transplanted, with ATN reported in 110 (17%). There were 262 recipients (40%) who experienced DGF and 38 (6%) who experienced graft failure. DGF occurred in 45% of kidneys with reported ATN compared with 39% without ATN (P=0.31) resulting in a relative risk (RR) of 1.13 (95% confidence interval [95% CI], 0.9 to 1.43) and a kidney donor risk index-adjusted RR of 1.11 (95% CI, 0.88 to 1.41). There was no significant difference in graft failure for kidneys with versus without ATN (8% versus 5%). In stratified analyses, the adjusted RR for DGF with ATN was 0.97 (95% CI, 0.7 to 1.34) for non-DCD kidneys and 1.59 (95% CI, 1.23 to 2.06) for DCD kidneys (P=0.02 for the interaction between ATN and DCD on the development of DGF). CONCLUSIONS: Despite a modest association with DGF for DCD kidneys, this study reveals no significant associations overall between preimplant biopsy-reported ATN and the outcomes of DGF or graft failure. The potential benefit of more rigorous ATN reporting is unclear, but these findings provide little evidence to suggest that current ATN reports are useful for predicting graft outcomes or deciding to accept or reject allograft offers.
Authors: Ina Jochmans; Cyril Moers; Jacqueline M Smits; Henri G D Leuvenink; Jürgen Treckmann; Andreas Paul; Axel Rahmel; Jean-Paul Squifflet; Ernest van Heurn; Diethard Monbaliu; Rutger J Ploeg; Jacques Pirenne Journal: Ann Surg Date: 2010-11 Impact factor: 12.969
Authors: T Sulikowski; K Tejchman; Z Ziętek; E Urasińska; L Domański; J Sieńko; M Romanowski; K Safranow; M Zukowski; A Ciechanowicz; K Ciechanowski; M Ostrowski Journal: Transplant Proc Date: 2010-11 Impact factor: 1.066
Authors: L K Kayler; P Garzon; J Magliocca; S Fujita; R D Kim; A W Hemming; R Howard; J D Schold Journal: Am J Transplant Date: 2009-02 Impact factor: 8.086
Authors: Bernd Schröppel; Bernd Krüger; Liron Walsh; Melissa Yeung; Shay Harris; Krista Garrison; Jonathan Himmelfarb; Susan M Lerner; Jonathan S Bromberg; Ping L Zhang; Joseph V Bonventre; Zhu Wang; Alton B Farris; Robert B Colvin; Barbara T Murphy; John P Vella Journal: J Am Soc Nephrol Date: 2009-12-17 Impact factor: 10.121
Authors: Panduranga S Rao; Douglas E Schaubel; Mary K Guidinger; Kenneth A Andreoni; Robert A Wolfe; Robert M Merion; Friedrich K Port; Randall S Sung Journal: Transplantation Date: 2009-07-27 Impact factor: 4.939
Authors: Ron Wald; Robert R Quinn; Jin Luo; Ping Li; Damon C Scales; Muhammad M Mamdani; Joel G Ray Journal: JAMA Date: 2009-09-16 Impact factor: 56.272
Authors: Cyril Moers; Jacqueline M Smits; Mark-Hugo J Maathuis; Jürgen Treckmann; Frank van Gelder; Bogdan P Napieralski; Margitta van Kasterop-Kutz; Jaap J Homan van der Heide; Jean-Paul Squifflet; Ernest van Heurn; Günter R Kirste; Axel Rahmel; Henri G D Leuvenink; Andreas Paul; Jacques Pirenne; Rutger J Ploeg Journal: N Engl J Med Date: 2009-01-01 Impact factor: 91.245
Authors: Areef Ishani; Jay L Xue; Jonathan Himmelfarb; Paul W Eggers; Paul L Kimmel; Bruce A Molitoris; Allan J Collins Journal: J Am Soc Nephrol Date: 2008-11-19 Impact factor: 14.978
Authors: Sumit Mohan; Mariana C Chiles; Rachel E Patzer; Stephen O Pastan; S Ali Husain; Dustin J Carpenter; Geoffrey K Dube; R John Crew; Lloyd E Ratner; David J Cohen Journal: Kidney Int Date: 2018-05-05 Impact factor: 10.612
Authors: Sumit Mohan; Eric Campenot; Mariana C Chiles; Dominick Santoriello; Eric Bland; R John Crew; Paul Rosenstiel; Geoffrey Dube; Ibrahim Batal; Jai Radhakrishnan; P Rodrigo Sandoval; James Guarrera; M Barry Stokes; Vivette D'Agati; David J Cohen; Lloyd E Ratner; Glen Markowitz Journal: J Am Soc Nephrol Date: 2017-07-06 Impact factor: 10.121
Authors: Dennis G Moledina; Isaac E Hall; Heather Thiessen-Philbrook; Peter P Reese; Francis L Weng; Bernd Schröppel; Mona D Doshi; F Perry Wilson; Steven G Coca; Chirag R Parikh Journal: Am J Kidney Dis Date: 2017-08-24 Impact factor: 8.860
Authors: Jingmao Chi; Yiwei Ma; Francis L Weng; Heather Thiessen-Philbrook; Chirag R Parikh; Henry Du Journal: J Biophotonics Date: 2017-05-09 Impact factor: 3.207
Authors: I E Hall; B Schröppel; M D Doshi; J Ficek; F L Weng; R D Hasz; H Thiessen-Philbrook; P P Reese; C R Parikh Journal: Am J Transplant Date: 2015-03-11 Impact factor: 8.086
Authors: Jeremy Puthumana; Isaac E Hall; Peter P Reese; Bernd Schröppel; Francis L Weng; Heather Thiessen-Philbrook; Mona D Doshi; Veena Rao; Chun Geun Lee; Jack A Elias; Lloyd G Cantley; Chirag R Parikh Journal: J Am Soc Nephrol Date: 2016-07-22 Impact factor: 10.121
Authors: Mona D Doshi; Peter P Reese; Isaac E Hall; Bernd Schröppel; Joseph Ficek; Richard N Formica; Francis L Weng; Rick D Hasz; Heather Thiessen-Philbrook; Chirag R Parikh Journal: Transplantation Date: 2017-06 Impact factor: 4.939